| Completed | A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modif Prostate Neoplasms, Prostate Cancer | Phase 2 | 2011-10-01 |
| Completed | A Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy Volunteers Pharmacokinetics | Phase 1 | 2010-05-01 |
| Completed | Impact of Tolerability Issues on Chronic Pain Pain | — | 2010-02-01 |
| Terminated | An Efficacy and Safety Study of Bortezomib in Participants Previously Treated for Multiple Myeloma With Limite Multiple Myeloma | Phase 2 | 2007-10-01 |
| Terminated | A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a H Schizophrenia | Phase 4 | 2006-01-01 |
| Completed | A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydroch Multiple Myeloma | Phase 2 | 2005-11-01 |
| Completed | A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole GERD | Phase 1 | 2005-10-01 |
| Completed | CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorde Depressive Disorder, Major | Phase 3 | 2005-06-01 |
| Completed | CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Attention Deficit Disorder With Hyperactivity | Phase 3 | 2005-03-01 |
| Completed | An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched Fro Schizophrenia | Phase 3 | 2004-10-01 |
| Completed | A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosi Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder | Phase 4 | 2004-10-01 |
| Completed | Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD Gastroesophageal Reflux, Heartburn | Phase 3 | 2004-07-01 |
| Completed | A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in P Bipolar Disorder | Phase 3 | 2004-01-01 |
| Completed | An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsive Headache | Phase 2 | 2003-04-01 |
| Completed | Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer Prostate, Carcinoma | Phase 3 | 2002-12-01 |
| Completed | An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contrace Female Contraception | Phase 4 | 2002-10-01 |
| Completed | A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autist DCild Development Disorders, Pervasive, Autistic Disorder, Developmental Disabilities | Phase 3 | 1999-08-01 |
| Completed | A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. Anemia, Kidney Failure, Left Ventricular Hypertrophy | Phase 3 | 1997-12-01 |
| Withdrawn | A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Anemia, Blood Transfusion, Orthopedic Surgery | Phase 3 | 1996-05-01 |
| No Longer Available | A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Multiple Myeloma | — | — |
| Completed | A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transf Anemia | Phase 2 | — |
| Completed | An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Def Attention Deficit Hyperactivity Disorder | Phase 3 | — |